Gennex Laboratories Intrinsic Value
Gennex Laboratories (GENNEX) median intrinsic value is ₹22.08 from 9 valuation models (range ₹5–₹33), vs current price ₹11.04 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Browse Gennex Laboratories financial data for revenue, profit, balance sheet and cash flow data.
GENNEX Valuation Methods Summary — DCF, Graham Number & P/E
Gennex Laboratories intrinsic value across 9 models vs current price ₹11.04 — upside/downside and value range per method. Also explore GENNEX stock price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹18.48 | ₹14.78 - ₹22.18 | +67.4% | EPS: ₹0.84, Sector P/E: 22x |
| Book Value Method | asset | ₹27.60 | ₹24.84 - ₹30.36 | +150.0% | Book Value/Share: ₹84.78, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹22.08 | ₹19.87 - ₹24.29 | +100.0% | Revenue/Share: ₹64.35, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹22.08 | ₹19.87 - ₹24.29 | +100.0% | EBITDA: ₹24.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹27.60 | ₹22.08 - ₹33.12 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹5.38 | ₹4.84 - ₹5.92 | -51.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹12.98 | ₹11.68 - ₹14.28 | +17.6% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹22.08 | ₹19.87 - ₹24.29 | +100.0% | ROE: 12.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹33.12 | ₹29.81 - ₹36.43 | +200.0% | EPS: ₹0.84, BVPS: ₹84.78 |
GENNEX Intrinsic Value vs Market Price — All Valuation Models
Gennex Laboratories fair value range ₹5–₹33 vs current market price ₹11.04 across 9 valuation models. For current market price and key ratios, visit Gennex Laboratories share price chart.
GENNEX Intrinsic Value Analysis — Undervalued or Overvalued?
Gennex Laboratories median intrinsic value ₹22.08, current price ₹11.04 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of GENNEX?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gennex Laboratories (GENNEX) is ₹22.08 (median value). With the current market price of ₹11.04, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹5.38 to ₹33.12, indicating ₹5.38 - ₹33.12.
Is GENNEX undervalued or overvalued?
Based on our multi-method analysis, Gennex Laboratories (GENNEX) appears to be trading below calculated value by approximately 100.0%.
GENNEX Financial Health — Key Ratios vs Industry Benchmarks
Gennex Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 10.65 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 15.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.58x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GENNEX Cash Flow Quality — Operating & Free Cash Flow
Gennex Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-11 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-47 Cr | ₹-47 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹24 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹12 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |